Holocene Advisors’s Immunocore IMCR Stock Holding History

Holocene Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-165,357	Closed	-$8.58M	–	764
2023 Q3	$8.58M	Sell	165,357 -528,606	-76%	-$31.3M	0.04%	301
2023 Q2	$41.6M	Sell	693,963 -31,994	-4%	-$1.83M	0.18%	150
2023 Q1	$35.9M	Buy	725,957 +127,244	+21%	+$7.16M	0.18%	158
2022 Q4	$34.2M	Buy	598,713 +97,646	+19%	+$5.5M	0.21%	132
2022 Q3	$23.5M	Buy	+501,067	New	+$23.9M	0.15%	173

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Holocene Advisors's IMCR Position: Q4 2023 in Review

Holocene Advisors sold out of Immunocore (IMCR) in Q4 2023, closing a stake of 165,357 shares — an estimated $8.58M sold.

Holocene Advisors first reported a position in IMCR in Q3 2022 and held it in 5 quarters. The position peaked at $41.6M in Q2 2023. 133 funds tracked by Wall St. Rank hold IMCR as of Q4 2023.

Holocene Advisors reported no remaining Immunocore position as of Q4 2023 after selling out during the quarter.
Holocene Advisors sold 165,357 Immunocore shares in Q4 2023, an estimated $8.58M.
Holocene Advisors first reported a position in Immunocore in Q3 2022 and held it in 5 quarters.
Holocene Advisors's Immunocore position peaked at $41.6M in Q2 2023.
133 funds tracked by Wall St. Rank held Immunocore as of Q4 2023.

Based on Holocene Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.